Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Executive or director change
  2. 4 Grant or award EVP, Chief Development Officer acquired 40,000 shares (grant or award)
  3. 4 Grant or award General Counsel acquired 22,500 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 22,500 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 22,500 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 8-K Event Regulation FD disclosure
  10. SC 13G Stake Amended Statement of Ownership
  11. CT ORDER Other Confidential Order
  12. SC 13G Stake Amended Statement of Ownership
  13. 8-K Event Results of operations
  14. 10-Q Report Quarterly Report
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 16 of 41 · 801 filings